Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Cardiomyopathy VI: Nursing Management

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Heart failure awareness and influencing factors among adults in the Jazan, Saudi Arabia.

Medicine·2026

Same author

Trends in telemedicine consultations by the ministry of health in Saudi Arabia from 2019 to 2023: Leadership implications from a retrospective study.

Digital health·2026

Same author

From Trauma to Resilience: A Systematic Review of Psychological Intervention Strategies for War-Affected Children and Adolescents.

Avicenna journal of medicine·2026

Same author

Evaluating the effectiveness of completely metal-free ceramic total knee replacement compared to traditional metal-based implants: a systematic review.

The Knee·2026

Same author

Comparison between home-based and supervised rehabilitation protocols after anterior cruciate ligament reconstruction: a systematic review and meta-analysis.

EFORT open reviews·2025

Same author

Prevalence and risk factors of gastroesophageal reflux disease among population of Saudi Arabia: A meta-analysis.

Saudi medical journal·2025

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Interleukin-6 Inhibition for Patients with Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.

Mohammed Y Alasmary¹, Mohammed J Almalki², Faisal H Almalki²

¹Faculty of Medicine, Najran University, Medical Department, Najran, Kingdom of Saudi Arabia.

Saudi Medical Journal

|June 15, 2026

Summary

Tocilizumab

Keywords:

Acute myocardial infarction Inflammation Interleukin-6 Ischemia reperfusion injury STEMI Tocilizumab

Related Experiment Videos

Last Updated: Jun 16, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Area of Science:

Cardiovascular Medicine
Immunology
Inflammation Research

Background:

Interleukin-6 (IL-6) plays a key role in inflammation and ischemia-reperfusion injury following acute myocardial infarction (AMI).
Tocilizumab, an IL-6 receptor inhibitor, has shown potential in mitigating myocardial damage in AMI patients.

Purpose of the Study:

To evaluate the clinical outcomes of IL-6 pathway blockade with tocilizumab in patients experiencing ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI).

Main Methods:

A systematic review and meta-analysis adhering to PRISMA guidelines was conducted.
Searches of major databases identified randomized controlled trials investigating IL-6 inhibition in AMI.
Key outcomes assessed included infarct size, biomarkers, major adverse cardiovascular events, and mortality.

Main Results:

Three trials with 344 patients were analyzed, all using tocilizumab for STEMI or NSTEMI.
No significant differences were observed in recurrent myocardial infarction or infection rates.
Early reductions in c-reactive protein (CRP) and troponin release were noted, indicating acute anti-inflammatory and cardioprotective effects.

Conclusions:

Tocilizumab exhibits early anti-inflammatory and cardioprotective effects in AMI.
However, consistent long-term clinical benefits are not yet proven.
Larger, long-term trials are necessary to confirm efficacy and safety in AMI management.